These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26298189)

  • 1. FOXA2 mRNA expression is associated with relapse in patients with Triple-Negative/Basal-like breast carcinoma.
    Perez-Balaguer A; Ortiz-Martínez F; García-Martínez A; Pomares-Navarro C; Lerma E; Peiró G
    Breast Cancer Res Treat; 2015 Sep; 153(2):465-74. PubMed ID: 26298189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of increased osteopontin and splice variant-c mRNA expression with HER2 and triple-negative/basal-like breast carcinomas subtypes and recurrence.
    Ortiz-Martínez F; Perez-Balaguer A; Ciprián D; Andrés L; Ponce J; Adrover E; Sánchez-Payá J; Aranda FI; Lerma E; Peiró G
    Hum Pathol; 2014 Mar; 45(3):504-12. PubMed ID: 24440093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Notch pathway down-regulation with Triple Negative/Basal-like breast carcinomas and high tumor-infiltrating FOXP3+ Tregs.
    Ortiz-Martínez F; Gutiérrez-Aviñó FJ; Sanmartín E; Pomares-Navarro E; Villalba-Riquelme C; García-Martínez A; Lerma E; Peiró G
    Exp Mol Pathol; 2016 Jun; 100(3):460-8. PubMed ID: 27118257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of the deregulated kallikrein-related peptidase 8 mRNA expression in breast cancer: a novel independent indicator of disease-free survival.
    Michaelidou K; Ardavanis A; Scorilas A
    Breast Cancer Res Treat; 2015 Jul; 152(2):323-36. PubMed ID: 26099606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of PTEN expression is associated with aggressive behavior and poor prognosis in Middle Eastern triple-negative breast cancer.
    Beg S; Siraj AK; Prabhakaran S; Jehan Z; Ajarim D; Al-Dayel F; Tulbah A; Al-Kuraya KS
    Breast Cancer Res Treat; 2015 Jun; 151(3):541-53. PubMed ID: 25981902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
    Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
    Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPARC overexpression in primary tumors correlates with disease recurrence and overall survival in patients with triple negative breast cancer.
    Zhu A; Yuan P; Du F; Hong R; Ding X; Shi X; Fan Y; Wang J; Luo Y; Ma F; Zhang P; Li Q; Xu B
    Oncotarget; 2016 Nov; 7(47):76628-76634. PubMed ID: 27421134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Transcriptome Profiling Reveals Multigene Signatures in Triple-Negative Breast Cancer.
    Liu YR; Jiang YZ; Xu XE; Hu X; Yu KD; Shao ZM
    Clin Cancer Res; 2016 Apr; 22(7):1653-62. PubMed ID: 26813360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low prognostic implication of fibroblast growth factor family activation in triple-negative breast cancer subsets.
    Lee HJ; Seo AN; Park SY; Kim JY; Park JY; Yu JH; Ahn JH; Gong G
    Ann Surg Oncol; 2014 May; 21(5):1561-8. PubMed ID: 24385208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular biomarkers for prediction of response to treatment and survival in triple negative breast cancer patients from Egypt.
    Bahnassy A; Mohanad M; Ismail MF; Shaarawy S; El-Bastawisy A; Zekri AR
    Exp Mol Pathol; 2015 Oct; 99(2):303-11. PubMed ID: 26232605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypermethylation of BRCA1 gene: implication for prognostic biomarker and therapeutic target in sporadic primary triple-negative breast cancer.
    Zhu X; Shan L; Wang F; Wang J; Wang F; Shen G; Liu X; Wang B; Yuan Y; Ying J; Yang H
    Breast Cancer Res Treat; 2015 Apr; 150(3):479-86. PubMed ID: 25783183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
    Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
    BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AKAP3 correlates with triple negative status and disease free survival in breast cancer.
    Esmaeili R; Majidzadeh-A K; Farahmand L; Ghasemi M; Salehi M; Khoshdel AR
    BMC Cancer; 2015 Oct; 15():681. PubMed ID: 26458542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRABP1 is associated with a poor prognosis in breast cancer: adding to the complexity of breast cancer cell response to retinoic acid.
    Liu RZ; Garcia E; Glubrecht DD; Poon HY; Mackey JR; Godbout R
    Mol Cancer; 2015 Jul; 14():129. PubMed ID: 26142905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The orphan nuclear receptor estrogen-related receptor beta (ERRβ) in triple-negative breast cancer.
    Fernandez AI; Geng X; Chaldekas K; Harris B; Duttargi A; Berry VL; Berry DL; Mahajan A; Cavalli LR; Győrffy B; Tan M; Riggins RB
    Breast Cancer Res Treat; 2020 Feb; 179(3):585-604. PubMed ID: 31741180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexpression of androgen receptor and FOXA1 in nonmetastatic triple-negative breast cancer: ancillary study from PACS08 trial.
    Guiu S; Charon-Barra C; Vernerey D; Fumoleau P; Campone M; Spielmann M; Roché H; Mesleard C; Arnould L; Lemonnier J; Lacroix-Triki M
    Future Oncol; 2015; 11(16):2283-97. PubMed ID: 26260807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between Mutation and Expression of
    Kim JY; Park K; Jung HH; Lee E; Cho EY; Lee KH; Bae SY; Lee SK; Kim SW; Lee JE; Nam SJ; Ahn JS; Im YH; Park YH
    Cancer Res Treat; 2016 Oct; 48(4):1338-1350. PubMed ID: 26910472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response.
    Jézéquel P; Loussouarn D; Guérin-Charbonnel C; Campion L; Vanier A; Gouraud W; Lasla H; Guette C; Valo I; Verrièle V; Campone M
    Breast Cancer Res; 2015 Mar; 17():43. PubMed ID: 25887482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ALDH1A1 mRNA expression in association with prognosis of triple-negative breast cancer.
    Liu Y; Baglia M; Zheng Y; Blot W; Bao PP; Cai H; Nechuta S; Zheng W; Cai Q; Shu XO
    Oncotarget; 2015 Dec; 6(38):41360-9. PubMed ID: 26462023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer.
    Mehner C; Hockla A; Miller E; Ran S; Radisky DC; Radisky ES
    Oncotarget; 2014 May; 5(9):2736-49. PubMed ID: 24811362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.